论文部分内容阅读
目的分析丹参联合低分子肝素预防妇科盆腔术后DVT的临床效果。方法将86例行盆腔手术治疗的患者随机分为两组各43例,治疗组给予丹参联合低分子肝素钙治疗,对照组仅给予低分子肝素钙治疗,比较两组临床疗效。结果治疗组术后发生DVT1例(2.33%),对照组发生6例(13.95%),组间差异有统计学意义(P<0.05);两组间FIB、TT、PT、APTT比较,差异均无统计学意义(P>0.05)。结论丹参联合低分子肝素对盆腔术后DVT形成预防作用较明显且安全有效,值得临床使用。
Objective To analyze the clinical effect of Danshen combined with low molecular weight heparin in preventing DVT after gynecological pelvic surgery. Methods A total of 86 patients undergoing pelvic surgery were randomly divided into two groups of 43 patients. The treatment group received Danshen combined with low molecular weight heparin calcium. The control group received only low molecular weight heparin calcium. The clinical efficacy was compared between the two groups. Results There were 6 cases (13.95%) of DVT occurred in the treatment group and 6 cases (13.95%) in the control group. The difference between the two groups was statistically significant (P <0.05). The differences of FIB, TT, PT and APTT No statistical significance (P> 0.05). Conclusion Danshen combined with low molecular weight heparin on postoperative pelvic DVT prevention is more obvious and safe and effective, worthy of clinical use.